MassachusettsState Snapshot for Children

In this comparison, the NHQDR measures for Massachusetts for the most recent data year and the baseline year are compared to the average of all States.

Historically, the State Snapshots have included State-specific estimates for selected AHRQ Quality Indicators (QIs) based on Healthcare Cost and Utilization Project (HCUP) data. The 2018 QDR does not include State-specific QI estimates based on 2016 HCUP data because the International Classification of Diseases, Tenth Revision, Clinical Modification/Procedure Coding System version of the QI software used did not include risk adjustment. State-specific QIs will be reported in future QDRs when the estimates can be risk adjusted.

Measures Better Than Average in The Recent Year

Measure	Population	Recent Year	Recent Rate	Recent Performance	Baseline Year	Baseline Rate	Baseline Performance
Adolescents ages 16-17 who received 1 or more doses of meningococcal conjugate vaccine	Total	2016	90.6	Better than Average	2008	46.9	Average
Adolescents ages 13-15 who received 1 or more doses of meningococcal conjugate vaccine	Total	2016	90.3	Better than Average	2008	61.2	Better than Average
Children ages 19-35 months who received 1 or more doses of measles-mumps-rubella vaccine	Total	2016	98.6	Better than Average	2000	96.1	Better than Average
Children ages 19-35 months who received 1 or more doses of varicella vaccine	Total	2016	97.0	Better than Average	2000	79.5	Better than Average
Children ages 19-35 months who received 4 or more doses of diphtheria-tetanus-pertussis vaccine	Total	2016	94.0	Better than Average	2000	87.7	Better than Average
Children ages 19-35 months who received 3 or more doses of hepatitis B vaccine	Total	2016	96.8	Better than Average	2000	93.3	Better than Average
Adolescents ages 13-15 who received 1 or more doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years	Total	2016	96.5	Better than Average	2008	49.8	Average
Adolescents ages 16-17 who received 1 or more doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) since the age of ten years	Total	2016	97.0	Better than Average	2008	32.3	Average

Measures That Are Average in The Recent Year

Measure	Population	Recent Year	Recent Rate	Recent Performance	Baseline Year	Baseline Rate	Baseline Performance
Children ages 19-35 months who received 3 or more doses of polio vaccine	Total	2016	99.6	Average	2000	94.1	Better than Average
Adolescent males ages 13-15 who received 3 or more doses of human papillomavirus (HPV) vaccine	Total	2016	32.9	Average			Missing